Hydrogel Implementing Drug Delivery in Cranial Bone Tissue Engineering
Journal of Functional Biomaterials · 14.08.2026 · 17 (8) · 401
DOI: 10.3390/jfb17080401 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 14.08.2026. Verfasst von Martina Salvati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 …. Die Arbeit nennt 294 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università Cattolica del Sacro Cuore.
Abstract (Originalsprache)
Cranial bone defects remain a significant clinical challenge due to their limited intrinsic regenerative capacity and the complexity of coordinating osteogenesis, angiogenesis, and immune responses within a confined and poorly vascularised environment. Conventional approaches, including autologous grafts and synthetic implants, provide structural support but fail to actively modulate the biological processes required for effective bone regeneration. In this context, hydrogel-based systems have emerged as versatile platforms for localized and controlled drug delivery in cranial bone tissue engineering (BTE). This review provides a comprehensive overview of hydrogel-based delivery strategies designed to regulate the spatiotemporal presentation of bioactive agents within cranial defects. The main classes of hydrogels, natural, synthetic, semi-synthetic, and hybrid systems, are discussed in relation to their physicochemical properties and suitability for drug delivery applications. Current delivery approaches are analysed, including cell-free systems (growth factors, peptides, bioactive ions, nucleic acids, and small molecules drugs), cell-based platforms, and multifunctional systems integrating secondary carriers such as nanoparticles (NPs), microparticles (MPs), and extracellular vesicles (EVs). Particular emphasis is placed on how hydrogel design parameters, including crosslinking density, degradation kinetics, and responsiveness to microenvironmental cues, govern therapeutic release and influence regenerative outcomes. Emerging strategies and key translational challenges are also highlighted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.
- Dipartimento Scienze Della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.
- Dipartimento di Scienze Biotecnologiche di Base, Cliniche, Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
- Fondazione IRCCS Casa Sollievo Della Sofferenza, Viale Cappuccini, 71013 San Giovanni Rotondo, Italy.
ORCID-Profile: Alessandro Arcovito, Ornella Parolini, Wanda Lattanzi
Förderung
- Università Cattolica del Sacro Cuore
Zitieren
APA
Salvati, M., Vita, A., Arcovito, A., Parolini, O., Tiberio, F., & Lattanzi, W. (2026). Hydrogel Implementing Drug Delivery in Cranial Bone Tissue Engineering. Journal of Functional Biomaterials, 17(8), 401. https://doi.org/10.3390/jfb17080401
Vancouver
Salvati M, Vita A, Arcovito A, Parolini O, Tiberio F, Lattanzi W. Hydrogel Implementing Drug Delivery in Cranial Bone Tissue Engineering. Journal of Functional Biomaterials. 2026;17(8):401. doi:10.3390/jfb17080401
BibTeX
@article{Salvati2026,
author = {Salvati, Martina and Vita, Alessia and Arcovito, Alessandro and Parolini, Ornella and Tiberio, Federica and Lattanzi, Wanda},
title = {Hydrogel Implementing Drug Delivery in Cranial Bone Tissue Engineering},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {8},
pages = {401},
doi = {10.3390/jfb17080401}
}
EUVIMED